您当前的位置：
首页 >
文章列表页 >
Efficacy and safety of letermovir in preventing cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
更新时间：2025-11-14

    • Efficacy and safety of letermovir in preventing cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation

    • “A study conducted by the Hematology Department of the First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine shows that early use of letemovir after allogeneic hematopoietic stem cell transplantation can significantly reduce the rate of cytomegalovirus infection and delay the infection time, with good safety in the short term.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 15, Pages: 1904-1909(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.15.15    

      CLC： R978.7;R551

    • Received：12 February 2025，

      Revised：2025-04-15，

      Accepted：04 July 2025，

      Published：15 August 2025

    移动端阅览

  • WANG Ranran,LI Shuyue,LIANG Ranran,et al.Efficacy and safety of letermovir in preventing cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation[J].ZHONGGUO YAOFANG,2025,36(15):1904-1909. DOI： 10.6039/j.issn.1001-0408.2025.15.15.

  •  
  •  

0

Views

44

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

棘白菌素类抗真菌药物预防侵袭性念珠菌血症有效性与安全性
低分子肝素钙预防ICU患者静脉血栓栓塞症的临床观察
氨磷汀预防化疗致周围神经毒性疗效与安全性的系统评价
达比加群酯与华法林用于非瓣膜性心房颤动患者抗凝的有效性与安全性比较
细菌溶解产物胶囊防治儿童反复呼吸道感染有效性和安全性的Meta分析

Related Author

LI Sha
DAI Libo
YAO Haitao
KONG Xudong
FU Zhenhui
REN Bo
ZHAO Qundu
WEI Xiaochen

Related Institution

No data
0